Picture of Neurosense Therapeutics logo

NRSN — Neurosense Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Neurosense Announces Third Quarter 2022 Financial Results And Provides Business Update

Dec 1 (Reuters) - Neurosense Therapeutics Ltd  NRSN.O :
    * NEUROSENSE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
    * NEUROSENSE THERAPEUTICS LTD - AS OF SEPTEMBER 30, 2022,
NEUROSENSE HAD CASH AND SHORT-TERM DEPOSITS OF $8.44 MILLION
    * NEUROSENSE THERAPEUTICS LTD - BELIEVES THAT CASH RESOURCES
WILL
BE SUFFICIENT TO CONTINUE DEVELOPMENT OF CO'S PRODUCT INTO Q4 OF
2023
    * NEUROSENSE THERAPEUTICS LTD - QTRLY LOSS PER SHARE $0.80

Source text for Eikon:  ID:nPnZz2pKa 
Further company coverage:  NRSN.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Neurosense Therapeutics

See all news